Skip to main content

Advertisement

SpringerLink
Log in

Reply to: “Current Challenges in Defining Futile Liver Resection and Predicting Early Recurrence After Curative-Intent Treatment for Colorectal Liver Metastases”, by Wong, Geoffrey Yuet Mun et al.

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fromer MW, et al. Preventing futile liver resection: a risk-based approach to surgical selection in major hepatectomy for colorectal cancer. Ann Surg Oncol. 2022;29(2):905–12.

    Article  PubMed  Google Scholar 

  2. Andreou A, et al. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford). 2011;13(11):774–82.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Vigano L, et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol. 2014;21(4):1276–86.

    Article  PubMed  Google Scholar 

  4. Sasaki K, et al. The tumor burden score: a new “Metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267(1):132–41.

    Article  PubMed  Google Scholar 

  5. Milosevic M, et al. Pulmonary metastasectomy in colorectal cancer: updated analysis of 93 randomized patients—control survival is much better than previously assumed. Colorectal Dis. 2020;22(10):1314–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hu Y, et al. Prognostic value of NRAS gene for survival of colorectal cancer patients: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2018;19(11):3001–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Karagkounis G, et al. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases. Cancer. 2013;119(23):4137–44.

    Article  CAS  PubMed  Google Scholar 

  8. Passiglia F, et al. Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2016;99:150–7.

    Article  PubMed  Google Scholar 

  9. Saravani K, Salarzaei M, Parooie F. Effect of KRAS and BRAF mutations in metastatic colorectal cancer patients: a systematic review and meta-analysis based on tumor sidedness and KRAS subtypes. Hum Antibodies. 2021;29(4):275–84.

    Article  CAS  PubMed  Google Scholar 

  10. Schirripa M, et al. Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer. Int J Cancer. 2015;136(1):83–90.

    Article  CAS  PubMed  Google Scholar 

  11. Tosi F, et al. Effect of KRAS and BRAF mutations on survival of metastatic colorectal cancer after liver resection: a systematic review and meta-analysis. Clin Colorectal Cancer. 2017;16(3):e153–63.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, University of Louisville, Louisville, USA

    Marc W. Fromer MD, MSc, Charles R. Scoggins MD, MBA, Michael E. Egger MD, MPH, Prejesh Philips MD, Kelly M. McMasters MD, PhD & Robert C. G. Martin II MD, PhD

Authors
  1. Marc W. Fromer MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles R. Scoggins MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael E. Egger MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prejesh Philips MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kelly M. McMasters MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert C. G. Martin II MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc W. Fromer MD, MSc.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fromer, M.W., Scoggins, C.R., Egger, M.E. et al. Reply to: “Current Challenges in Defining Futile Liver Resection and Predicting Early Recurrence After Curative-Intent Treatment for Colorectal Liver Metastases”, by Wong, Geoffrey Yuet Mun et al.. Ann Surg Oncol 30, 5461–5462 (2023). https://doi.org/10.1245/s10434-022-13046-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-13046-2

Search

Navigation